SCHEMBL2497840

SCHEMBL2497840

CC(C)(C)c1cccc(O)c1Br

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
TDP1 Q9NUW8 3/20 0.60
TSHR P16473 1/20 0.60
CA2 P00918 5/20 0.56
GABRA1 P14867 1/20 0.48
GABRB2 P47870 1/20 0.48
ALOX15 P16050 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
CYP1A2 P05177 1/20 0.42
ATP2A2 P16615 1/20 0.42
ATP2A3 Q93084 1/20 0.42
LMNA P02545 3/20 0.40
HSD17B10 Q99714 3/20 0.40
TYR P14679 2/20 0.40
NR1I2 O75469 1/20 0.40
CYP2C9 P11712 1/20 0.40
MIF P14174 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2201130 0.83 CA2 (0.55) ALDH1A1TDP1TSHRCA2GABRA1
SCHEMBL574123 0.79 ALDH1A1 (0.42) ALDH1A1TDP1TSHRCA2GABRA1
SCHEMBL30605901 0.77 TAS2R14 (0.44) ALDH1A1TDP1TSHRCA2ALOX15
SCHEMBL1854326 0.77 TAS2R14 (0.44) ALDH1A1TDP1TSHRCA2ALOX15
SCHEMBL36109 0.76 CA2 (0.76) ALDH1A1TDP1TSHRCA2GABRA1
SCHEMBL29888677 0.76 ALDH1A1 (0.65) ALDH1A1TDP1TSHRCA2GABRA1
SCHEMBL29169320 0.76 ALDH1A1 (0.65) ALDH1A1TDP1TSHRCA2GABRA1
SCHEMBL30504750 0.76 CA2 (0.76) ALDH1A1TDP1TSHRCA2GABRA1
SCHEMBL6681932 0.76 CA2 (0.48) ALDH1A1TDP1TSHRCA2GABRA1
SCHEMBL22729938 0.75 ALDH1A1 (1.00) ALDH1A1TDP1TSHRCA2GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122037020-A Supported catalyst, preparation method thereof and application thereof in olefin polymerization 中国石油化工股份有限公司 2026-05-15 CN claimed
CN-122037020-A Supported catalyst, preparation method thereof and application thereof in olefin polymerization 中国石油化工股份有限公司 2026-05-15 CN disclosed
CN-112679635-B Preparation method of supported metallocene catalyst and catalyst prepared by preparation method 中国石油化工股份有限公司 2024-03-26 CN disclosed
CN-112679635-A Preparation method of supported metallocene catalyst and catalyst prepared by same 中国石油化工股份有限公司 2021-04-20 CN disclosed
CN-105392779-B Tetrazolinone compound and use thereof 住友化学株式会社 2018-01-19 CN disclosed
CN-105392779-A Tetrazolinone compound and use thereof SUMITOMO CHEMICAL CO 2016-03-09 CN disclosed
US-8030516-B2 Methods for producing perfluoroalkanedi(sulfonyl chloride) UBE INDUSTRIES, LTD. (JP) 2011-10-04 US disclosed
US-20090105502-A1 METHODS FOR PRODUCING PERFLUOROALKANEDI(SULFONYL CHLORIDE) IM&T RESEARCH, INC. (US) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105502-A1 METHODS FOR PRODUCING PERFLUOROALKANEDI(SULFONYL CHLORIDE) PFAS, PFKFB1, PFKFB2 ALDH1A1 2503/4885TDP1 4068/4885TSHR 686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.